...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Liquidity
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Thanks KBC.

I'm really hoping you are right and that it is an urgent issue for Don.

By the way with my little thought experiment re Dragons Den and Shark Tank I must say that Resverlogix has been attracting capital consistently for over 15 years (I believe because of the science) and in this regard RVX has been far more successful than most of the Dragons and Sharks. Anyway, it was just a bit of fun!

Beautiful day in Muskoka and I'm headed out for an LSJ.

GLTA

Toinv

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply